Researchers from Leiden University Medical Center (LUMC) and the Leiden-based biotech company Ncardia have joined forces to ...

Phenotypic 3D cell models incorporate tissue architectures and extracellular matrices to recapitulate the complexity of the ...

MANASSAS, Va. & TEL AVIV, Israel--(BUSINESS WIRE)--ATCC, the world’s premier biological materials management and standards organization, and Tissue Dynamics, a disruptive pharma-tech company ...

Advances in biofabrication and 3D in vitro model systems are transforming biomedical research, drug development, and toxicity testing. However, despite ...

Researchers at Korea University applied magnetic torque stimulation to stem cell-derived cardiac organoids, activating ...

Explore the potential of heart organoids in understanding cardiac disorders and developing new treatment methods.

In a recent study, the regulatory role of the long noncoding RNA (lncRNA) Gm20257 in pathological cardiac hypertrophy has been elucidated, offering new insights into potential therapeutic targets.

In this whitepaper, Sartorius discusses the need to replace animal testing with advanced in vitro human cell models for pharmaceutical, chemical, and cosmetic development as, with only 5-10% of ...

Personalized treatment for patients with heart failure and repairing heart damage after a heart attack. These are two of the seven research programs ...